![Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University](https://gumc.georgetown.edu/wp-content/uploads/2018/11/Gia.jpg)
Giuseppe Giaccone: Leading Clinical Oncology Research Expansion | Georgetown University Medical Center | Georgetown University
![ITMIG 2017# Interview with Dr. Giuseppe Giaccone: We should focus on data, and keep up-to-date - YouTube ITMIG 2017# Interview with Dr. Giuseppe Giaccone: We should focus on data, and keep up-to-date - YouTube](https://i.ytimg.com/vi/0DHdq_kweU4/maxresdefault.jpg)
ITMIG 2017# Interview with Dr. Giuseppe Giaccone: We should focus on data, and keep up-to-date - YouTube
![2016 - Lung Cancer Research Foundation Annual Grant Program - Georgetown University - Giuseppe Giaccone, MD, PhD - Lung Cancer Research Foundation 2016 - Lung Cancer Research Foundation Annual Grant Program - Georgetown University - Giuseppe Giaccone, MD, PhD - Lung Cancer Research Foundation](https://www.lungcancerresearchfoundation.org/wp-content/uploads/Giaccone.jpg)
2016 - Lung Cancer Research Foundation Annual Grant Program - Georgetown University - Giuseppe Giaccone, MD, PhD - Lung Cancer Research Foundation
![PDF) Updated Overall Survival Analysis From IMpower110: Atezolizumab versus Platinum-Based Chemotherapy in Treatment-Naive PD-L1–Selected Non-Small Cell Lung Cancer PDF) Updated Overall Survival Analysis From IMpower110: Atezolizumab versus Platinum-Based Chemotherapy in Treatment-Naive PD-L1–Selected Non-Small Cell Lung Cancer](https://i1.rgstatic.net/publication/353199092_Updated_Overall_Survival_Analysis_From_IMpower110_Atezolizumab_versus_Platinum-Based_Chemotherapy_in_Treatment-Naive_PD-L1-Selected_Non-Small_Cell_Lung_Cancer/links/611e1a601e95fe241ae07736/largepreview.png)
PDF) Updated Overall Survival Analysis From IMpower110: Atezolizumab versus Platinum-Based Chemotherapy in Treatment-Naive PD-L1–Selected Non-Small Cell Lung Cancer
![The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification. - ppt download The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification. - ppt download](https://slideplayer.com/15501552/93/images/slide_1.jpg)
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposals for the N and M Components for the Forthcoming (8th) Edition of the TNM Classification. - ppt download
![Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology](https://cdn.mdedge.com/files/s3fs-public/styles/teaser_opengraph/public/Giaccone_Giuseppe_DC_143563_web.jpg)
Atezolizumab bests chemo in NSCLC patients with high PD-L1 expression | MDedge Hematology and Oncology
GIUSEPPE GULLO,MD,Ph.D - IVF Ob/Gyn Consultant - az.osp.ospedali riuniti villa sofia-cervello | LinkedIn
![Frontiers in Oncology on X: "We are happy to announce that Wafik El-Deiry of Brown University (@BrownMedicine) is joining Giuseppe Giaccone as the new co-Chief Editor for our Cancer Molecular Targets and Frontiers in Oncology on X: "We are happy to announce that Wafik El-Deiry of Brown University (@BrownMedicine) is joining Giuseppe Giaccone as the new co-Chief Editor for our Cancer Molecular Targets and](https://pbs.twimg.com/media/D54rkMVWsAEdk29.jpg)